Showing 291-300 of 1354 results for "".
Neuro-Oncology Outlook: Advancements in Targeted Molecular Therapy for Low-Grade Gliomas—Challenging the Treatment Paradigm
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuro-oncology-outlookbradvancements-in-targeted-molecular-therapy-for-low-grade-gliomas-challenging-the-treatment-paradigm/32121/Treatment with the IDH inhibitor vorasidenib increased median progression-free survival and time to next intervention in individuals with grade 2 gliomas under surveillance after surgical resection.Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.Susac Syndrome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/susac-syndrome/31619/A triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss.Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
https://practicalneurology.com/columns/practice-management/microplastics-and-negative-neuroplasticity/39811/Microplastics are neurotoxic in nature and can enter and accumulate in the brain, raising many questions concerning their role in common neurologic illnesses.Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31423/In July 2005, Practical Neurology highlighted the controversial remarks made by actor Tom Cruise regarding the field of psychiatry, reflecting broader implications for mental health advocacy and public perception. Cruise’s outspoken criticism emerged shortly after a public dispute with Brooke Shield
An Overview of Neurologic Complications of HIV and Opportunistic Infections
https://practicalneurology.com/diseases-diagnoses/imaging-testing/an-overview-of-neurologic-complications-of-hiv-and-opportunistic-infections/32154/Despite advances in treatment, neurologic complications remain prevalent in people with HIV infection.Neuromuscular Medicine & COVID-19
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-medicine-covid-19/31744/A myriad of neuromuscular complications have been associated with COVID-19 and individuals with underlying neuromuscular conditions have been affected as well.Frontotemporal Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/frontotemporal-dementias/31537/Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.